Hap Trading, LLC Corcept Therapeutics Inc Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $610,775 - $948,199	-27,500 Reduced 55.0%	22,500 $151 Million
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $1.06 Million - $1.37 Million	50,000 New	50,000 $144 Million
Q1 2022 May 12, 2022	SELL	$16.53 - $25.21 $204,972 - $312,604	-12,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $186,390 - $254,406	-10,900 Reduced 46.78%	12,400 $3,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $290,318 - $465,534	23,300 New	23,300 $53,000

349

86.4M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.